This bill aims to improve access to substance use disorder treatment in New Jersey by mandating Medicaid coverage for services provided by community-based organizations, which are defined as organizations licensed by the Department of Health to offer these services to Medicaid recipients. It introduces new definitions and standards for medication units associated with opioid treatment programs, allowing them to provide services such as intake assessments, medication-assisted treatment, and telecounseling. The legislation emphasizes individualized treatment plans and harm reduction services, ensuring that patients cannot be denied treatment based solely on their refusal of counseling or missed doses. Additionally, it removes outdated requirements regarding the location of treatment centers in relation to schools.

The bill also streamlines the licensure process for substance use disorder treatment centers and establishes specific operational guidelines for opioid treatment programs, including the flexibility to not require a pharmacist and limiting drug screenings to eight per year. It mandates the establishment of standards for the licensure of community-based organizations and includes provisions for training and technical assistance to help these organizations comply with Medicaid enrollment standards. Overall, the legislation seeks to enhance the quality and accessibility of substance use disorder services in the state, providing comprehensive support for individuals in need.

Statutes affected:
Introduced: 26:2H-11.1, 30:4D-6